Esophageal cancer in octogenarians: Should esophagectomy be done?

医学 食管切除术 危险系数 食管癌 置信区间 优势比 癌症 内科学 外科 回顾性队列研究 单中心 胃肠病学
作者
Lisa Cooper,Ran Orgad,Y Levi,Hila Shmilovitch,Yael Feferman,Daniel Solomon,Hanoch Kashtan
出处
期刊:Journal of Geriatric Oncology [Elsevier BV]
卷期号:15 (2): 101710-101710 被引量:1
标识
DOI:10.1016/j.jgo.2024.101710
摘要

Abstract

Introduction

Esophagectomy is the treatment of choice for esophageal cancer. In octogenarians data is conflicting. We evaluated postoperative outcomes and long-term survival of octogenarians and their younger counterparts.

Materials and Methods

A retrospective analysis of a prospectively maintained database including consecutive patients with esophageal cancer who underwent esophagectomy at a large referral, academic center between 2012 and 2021. Subgroups were designed according to age (<70, 70–79, and ≥ 80).

Results

A total of 359 patients underwent esophagectomy for esophageal cancer, 223 (62%) aged <70, 107 (30%) aged 70–79 and 29 (8%) aged ≥80. Octogenarians had higher American Society of Anesthesiologists [ASA] scores (p = 0.001), and fewer received neoadjuvant therapy (p = 0.04). Octogenarians experienced more major complications (P < 0.001) with significantly higher 30-day mortality rate (P = 0.001). In a multivariable analysis, major complications were associated with higher risk of being discharged to a rehabilitation center (odds ratio [OR] 14.839, 95% confidence interval [CI] 4.921–44.747, p < 0.001) while age was not. Overall survival was reduced in octogenarians, with a 50th percentile survival of 10 months compared to 32 and 26 months in patients age < 70 and 70–79, respectively (p = 0.014). In a multivariable analysis, age ≥ 80 (hazard ratio [HR] 4.478 95% CI 2.151–9.322, p < 0.001), cancer stage (HR 1.545, 95% CI 1.095–2.179, p = 0.013), and postoperative major complications (HR 2.705 95% CI 1.913–3.823, p < 0.001) were independently associated with reduced survival.

Discussion

Our study showed that octogenarians had significantly higher postoperative major complications compared to younger age groups. Overall survival was significantly reduced in these patients, probably due to an increased rate of perioperative mortality. Better patient selection and preparation may improve postoperative outcomes and increase long-term survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研王子发布了新的文献求助10
1秒前
PAPA发布了新的文献求助10
1秒前
tecumseh发布了新的文献求助10
1秒前
搜集达人应助冷酷的可乐采纳,获得10
1秒前
1秒前
Nala完成签到,获得积分10
1秒前
2秒前
哭泣乌发布了新的文献求助10
2秒前
2秒前
z1z1z发布了新的文献求助20
2秒前
大模型应助ZhijunXiang采纳,获得10
2秒前
善良的灵羊完成签到 ,获得积分10
3秒前
zhijianzhe应助喝一碗粥采纳,获得10
3秒前
王淑华发布了新的文献求助10
3秒前
3秒前
4秒前
婷婷发布了新的文献求助40
4秒前
量子星尘发布了新的文献求助10
4秒前
5秒前
5秒前
jieyu完成签到 ,获得积分10
5秒前
6秒前
虚幻沛菡发布了新的文献求助10
6秒前
兴奋如松完成签到,获得积分20
6秒前
6秒前
SciGPT应助Francisco2333采纳,获得10
7秒前
儒雅的李星云完成签到,获得积分10
8秒前
活泼的小袁完成签到 ,获得积分10
8秒前
深情安青应助lipeng采纳,获得10
8秒前
8秒前
ding应助wuhuhu采纳,获得10
8秒前
YY发布了新的文献求助10
8秒前
9秒前
居选金发布了新的文献求助10
10秒前
lvv完成签到,获得积分10
10秒前
10秒前
1112678发布了新的文献求助10
11秒前
邓佳鑫Alan应助优雅的千凝采纳,获得10
11秒前
电闪发布了新的文献求助10
11秒前
英俊的铭应助哭泣乌采纳,获得10
12秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Christian Women in Chinese Society: The Anglican Story 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961655
求助须知:如何正确求助?哪些是违规求助? 3507998
关于积分的说明 11139004
捐赠科研通 3240407
什么是DOI,文献DOI怎么找? 1790947
邀请新用户注册赠送积分活动 872683
科研通“疑难数据库(出版商)”最低求助积分说明 803306